Drreddys Laboratories reported 45.52B in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Ani Pharmaceuticals ANIP:US $ 83.67M 980K
Aurora Cannabis Inc ACB:CN 1.05B 921.9M
Bayer BAYN:GR 10.43B 1.33B
Canopy Growth Corp WEED:CN C$ 641.41M 350.48M
Catalent CTLT:US $ 1.06B 6M
Cipla CIPLA:IN 48.58B 3.63B
Corcept Therapeutics CORT:US $ 66.92M 4.76M
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Hikma Pharmaceutical HIK:LN 1.08B 209M
Horizon Pharma HZNP:US $ 690.93M 90.45M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Lannett LCI:US $ 100.44M 54.15M
Lonza Group LONN:SW 2.33B 108M
Novartis NOVN:VX 9.96B 998M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Prestige Brands PBH:US $ 189.51M 2.36M
Richter Gedeon RICHT:HB 130.57B 3.82B
Sun Pharmaceuticals SUNP:IN IR 117596.3M 39598.1M
Supernus Pharmaceuticals SUPN:US $ 150.54M 2.41M
Teva Pharmaceutical TEVA:IT 4.37B 352M